You have 9 free searches left this month | for more free features.

Condition

Cancer (1)

Non-small Cell Lung Cancer (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Lycera Corp. (2)

Collaborator

Intervention

lyc-55716 (2)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

lyc-55716

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC Trial in United States (LYC-55716, Pembrolizumab)

Unknown status

Non-small Cell Lung Cancer

LYC-55716
Pembrolizumab

Aurora, Colorado
+3 more

Sep 24, 2019

Cancer Trial in United States (LYC-55716)

Completed

Cancer

LYC-55716

Huntsville, Alabama
+19 more

Sep 24, 2019